Drug intelligence / Profile preview

Chlorphenesin

Development stage: Preclinical
Modality: Small Molecules
Administration: Topical

Overview

Chlorphenesin is an organic compound primarily utilized as a biocide and preservative in cosmetic products, where it demonstrates antimicrobial activity against various bacteria and fungi. It is also a known metabolite of chlorphenesin carbamate, a skeletal muscle relaxant. Due to its shared metabolite, 4-chlorophenoxyacetic acid (4-CPA), with the prohibited stimulant meclofenoxate, chlorphenesin's presence in cosmetics has implications for anti-doping tests. Furthermore, chlorphenesin has been identified as a putative repurposing drug for kidney cancers.

Beyond the preview

Go deeper on Chlorphenesin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chlorphenesin.

Explore the full profile